![]() |
||
|
Zimmern Wang,
MD
Professor Director, Otolaryngology Center for Innovative Technology Research Interests: 1R03CA112670-01; Biofilm chemoprevention of head/neck skin cancer. The
goals of this study to test a new, topical and less-toxic strategy by
polymer film delivered Celecoxib for prevention or early treatment of
head/neck cancers 1R01DC006617-01A1; NIH of NIDCD Voice-preserving treatment of laryngeal
papilloma. The goals of this study are to determine if a combined treatment
of pulsed dye laser and Celecoxib will reduce the trauma to vocal cords
and prevent papilloma from recurring Office-based CO2 laser therapy of laryngeal papilloma: (with Dr. Devaiah) Since May 1 of 2004, our group has conducted a series of animal studies in vitro and vivo model, to test a a newly-developed flexible CO2 laser fiber delivery system (made at Omniguide Communications, Mass). With our encouraging findigns. Our findings have been presented at Triological Meeting of 2005 by Dr. Devaiah, and , and alread accepted by Laryngoscope. We also submitted a R21 grant proposal to NIH, to request a support for our clinical trial to test this system for larygneal papilloma and other head/neck diseases. By using thei flexible endoscope and under non-general anesthesia at office, it is very likely that this new system will be an ideal alternative, to traditional rigid system for CO2 laser surgery. (submitted to NIH) Publications: Driver M, Upadhyay UD, Shapshay SM, Wang Z: Cancer chemoprevention with
laser assisted low- Wang Z.The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors. Curr Pharm Des 11(14):1771-7, 2005. Devaiah AK, Dasai U, Wang Z, Shapira G, Weisberg O, Torres DS, Shapshay SM., Surgical utility of a new CO2 laser fiber. Laryngoscope 2005. (accepted) Wang Z, Devaiah AK, Dasai U, Shapira G, Weisberg O, Torres DS, Shapshay
SM., Fiber-guided CO2 laser surgery in animal model. Laser Surg Med 2005.
(submitted) |
![]()
|
|